← Unusual insider activity · Company hub
BDX Becton, Dickinson and Co.
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$1.3M net selling - trailing 90 days
0 buyers - 4 unique sellers
Historical context: most recent complete month (2026-09) is the 71st percentile of this ticker's monthly net P/S flow over 24 complete months. Lower percentiles are more selling; higher are more buying. P10–P90: -$711K to $0.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| Polen Thomas E Jr | Chairman, CEO and President | -~$0.8M | 1 |
| Goette Roland | EVP and President, EMEA | -~$0.4M | 1 |
| Feld Michael | EVP, Chief Revenue Officer | -~$43K | 2 |
| Feld Michael | EVP, Chief Revenue Officer | -~$14K | 1 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 28, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -76 | 183.7 | ~$14K |
| August 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -165 | 188.49 | ~$31K |
| August 13, 2026 | Polen Thomas E Jr | Chairman, CEO and President | S | -4152 | 185 | ~$0.8M |
| August 11, 2026 | Goette Roland | EVP and President, EMEA | S | -2438 | 180.84 | ~$0.4M |
| July 27, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -75 | 157.13 | ~$12K |
| June 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -75 | 152.8 | ~$11K |
| June 24, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | -1100 | 145.66 | ~$0.2M |
| June 10, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | -1100 | 151.48 | ~$0.2M |
| June 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | S | -2764 | 146.35 | ~$0.4M |
| May 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -75 | 147.35 | ~$11K |
| April 27, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -74 | 151.94 | ~$11K |
| March 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -75 | 156.83 | ~$12K |
| February 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | -75 | 181.84 | ~$14K |
| February 18, 2026 | SCOTT BERTRAM L | — | S | -953 | 182.61 | ~$0.2M |
| January 26, 2026 | Feld Michael | EVP, CRO & Pres. Life Sciences | S | -75 | 202.73 | ~$15K |
| January 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | 2 reported sale rows | 1610 | — | ~$0.3M |
| January 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | -1010 | 206.54 | ~$0.2M |
| January 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | -600 | 209 | ~$0.1M |
| December 26, 2025 | Feld Michael | EVP, CRO & Pres. Life Sciences | S | -74 | 196.08 | ~$15K |
| December 17, 2025 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | -629 | 196.03 | ~$0.1M |
| December 1, 2025 | Feld Michael | EVP, CRO & Pres. Life Sciences | S | -75 | 193.36 | ~$15K |
| November 7, 2025 | SCOTT BERTRAM L | — | S | -217 | 176.58 | ~$38K |
| October 27, 2025 | Feld Michael | EVP & President, Life Sciences | S | -57 | 186.01 | ~$11K |
| September 26, 2025 | Feld Michael | EVP & President, Life Sciences | S | -58 | 181.03 | ~$10K |
| September 10, 2025 | Fraser Claire | — | S | -917 | 187.5 | ~$0.2M |
| August 22, 2025 | Feld Michael | EVP & President, Life Sciences | S | -57 | 197.99 | ~$11K |
| August 11, 2025 | HAYES GREGORY | — | P | 5250 | 191.57 | ~$1.0M |
| August 8, 2025 | Fraser Claire | — | S | -863 | 192.3 | ~$0.2M |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | 2 reported sale rows | 1185 | — | ~$0.2M |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | S | -1184 | 180.29 | ~$0.2M |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | S | -1 | 181.5 | ~$0K |
| June 2, 2025 | Shan David | EVP and Chief ISC Officer | S | -1166 | 171.19 | ~$0.2M |
| April 9, 2025 | Garrison Michael David | EVP & President, Medical | S | -479 | 197.28 | ~$94K |
| March 18, 2025 | Byrd Richard | EVP & President Interventional | S | -459 | 230 | ~$0.1M |
| March 12, 2025 | Byrd Richard | EVP & President Interventional | S | -1940 | 224.91 | ~$0.4M |
| February 12, 2025 | SCOTT BERTRAM L | — | S | -700 | 227.99 | ~$0.2M |
| February 10, 2025 | Henderson Jeffrey William | — | P | 1500 | 233.62 | ~$0.4M |
| January 21, 2025 | Neal Shana Carol | EVP and Chief People Officer | S | -787 | 240 | ~$0.2M |
| January 21, 2025 | Shan David | EVP and Chief ISC Officer | S | -500 | 240 | ~$0.1M |
| January 17, 2025 | Garrison Michael David | EVP & President, Medical | S | -597 | 236.51 | ~$0.1M |
| January 7, 2025 | Neal Shana Carol | EVP and Chief People Officer | S | -788 | 235 | ~$0.2M |
| December 19, 2024 | Garrison Michael David | EVP & President, Medical | S | -2838 | 223.33 | ~$0.6M |
| December 9, 2024 | Goette Roland | EVP and President, EMEA | S | -638 | 219.03 | ~$0.1M |
| December 6, 2024 | Goette Roland | EVP and President, EMEA | S | -4483 | 221.01 | ~$1.0M |
| December 6, 2024 | Neal Shana Carol | EVP and Chief People Officer | S | -1000 | 220.49 | ~$0.2M |
| December 5, 2024 | Shan David | EVP and Chief ISC Officer | S | -1500 | 220.25 | ~$0.3M |